Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Silence Therapeutics plc (SLN) Institutional Ownership & Insider Trading

70 institutions reported holding Silence Therapeutics plc shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SLNSilence Therapeutics plcFollow SLN — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
929.3M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

70 institutions held 16.0% of the shares. Across filers that reported both quarters, shares held changed +19.9%.

Increased+22New+18Decreased-14Closed-4

Largest moves, shares (millions)

Soleus Capital Management+0.6MBalyasny Asset Management+0.6MNantahala Capital Management+0.5MGreat Point Partners-0.6MJones Hill Capital-0.3MSG Americas Securities-0.3M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-1.1Sep 24-2.8Dec 24-2.9Mar 25-3.1Jun 25-0.1Sep 25-0.4Dec 25+1.4Mar 26+3.8Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 267023+19.9%2218144
Mar 265519+7.8%245115
Dec 255617-2.2%1311158
Sep 255319-0.5%124127
Jun 255519-15.2%881913
Mar 255922-12.3%1552311
Dec 246425-10.2%22141219
Sep 246728-4.5%23121414

Silence Therapeutics plc — questions

Who owns Silence Therapeutics plc stock?
70 institutions reported Silence Therapeutics plc shares in 13F filings for the quarter ended 2026-06-30. The largest: Siren, L.L.C. (2.3%), TCG Crossover Management, LLC (2.1%), Nantahala Capital Management, LLC (1.9%).

Every figure on this page comes from Silence Therapeutics plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.